Same Indication

Ipilimumab vs Valproic Acid

Ipilimumab vs Valproic Acid: Overview

This comparison examines the pharmacological differences between Ipilimumab and Valproic Acid.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Valproic Acid: Enhances GABA transmission and blocks sodium/calcium channels.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days; Valproic Acid β€” 9-16 hours.

Chemical Properties

Molecular Formula: Valproic Acid β€” C8H16O2.

Molecular Weight: Valproic Acid β€” 144.2110 g/mol.

Type: Ipilimumab β€” Antibody; Valproic Acid β€” Small molecule.